Kissei Pharmaceutical Co (JP:4547) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Kissei Pharmaceutical Co., Ltd. has announced its decision to acquire up to 1,400,000 of its own shares, representing 3.17% of the total issued shares, as part of a strategy to enhance capital efficiency and shareholder returns. The transaction will be conducted through the Tokyo Stock Exchange’s off-auction trading system, with a maximum acquisition cost set at 5.29 billion yen. The company also plans to cancel all treasury shares acquired during this process by November 29, 2024.
For further insights into JP:4547 stock, check out TipRanks’ Stock Analysis page.